Skip to content

ORBIMED ADVISORS LLC

Follow

13F filer, CIK 1055951, New York, NY

ORBIMED ADVISORS LLC reported $5,498,486,689 across 124 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 49.09% of the portfolio.

Accepted , ingested 13F-HR 0001172661-26-005349

Period
2026-09-30
Reported value
$5.5B
Holdings
124
Top 10 weight
49.09%
New
33
Sold out
38

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • ASPE ASPEN NEUROSCIENCE INC: 13D 3,589,132 shares, 12.3% of the class, 13D filed 2026-11-06, 0000947871-26-000996Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ADRXnew+24,205,789$483M
BRVEnew+12,175,159$246M
ETRAnew+6,885,170$77.5M
TNGXnew+2,777,621$69.3M
ABBVnew+259,600$67.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AZNreduced-536,400-$87.4M
DYNexited-3,235,684-$71.9M
CGONexited-972,800-$69.1M
BSXexited-1,483,200-$63.3M
XENEexited-892,471-$53.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001172661-26-005349, largest first. % of portfolio is the value over $5,452,834,306, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 15,021,721 shares; 2025Q1: 15,021,721 shares; 2025Q2: 15,518,492 shares; 2025Q3: 15,518,492 shares; 2025Q4: 15,518,492 shares; 2026Q1: 15,518,492 shares; 2026Q2: 15,518,492 shares; 2026Q3: 15,518,492 shares 15,518,492$630M11.55%0Timeline
ADRXADARX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 24,205,789 shares 24,205,789$483M8.85%newTimeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,959,538 shares; 2025Q1: 7,959,538 shares; 2025Q2: 7,959,538 shares; 2025Q3: 7,959,538 shares; 2025Q4: 7,959,538 shares; 2026Q1: 7,959,538 shares; 2026Q2: 6,776,632 shares; 2026Q3: 6,776,632 shares 6,776,632$311M5.7%0Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 337,600 shares; 2025Q1: 337,600 shares; 2025Q2: 337,600 shares; 2025Q3: 301,200 shares; 2025Q4: 301,200 shares; 2026Q1: 236,800 shares; 2026Q2: 257,900 shares; 2026Q3: 257,900 shares 257,900$298M5.47%0Timeline
BRVEBRAVEHEART BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 12,175,159 shares 12,175,159$246M4.51%newTimeline
SVASINOVAC BIOTECH LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,718,735 shares; 2025Q1: 2,718,735 shares; 2025Q2: 2,718,735 shares; 2025Q3: 2,718,735 shares; 2025Q4: 2,718,735 shares; 2026Q1: 2,718,735 shares; 2026Q2: 2,718,735 shares; 2026Q3: 2,718,735 shares 2,718,735$196M3.59%0Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,812,215 shares; 2025Q1: 4,002,887 shares; 2025Q2: 4,002,887 shares; 2025Q3: 4,002,887 shares; 2025Q4: 3,935,203 shares; 2026Q1: 3,637,887 shares; 2026Q2: 3,428,736 shares; 2026Q3: 3,074,853 shares 3,074,853$180M3.31%-353,883Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 829,900 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 663,400 shares; 2026Q2: 663,400 shares; 2026Q3: 946,100 shares 946,100$137M2.52%+282,700Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 435,200 shares; 2026Q2: 583,700 shares; 2026Q3: 584,100 shares 584,100$104M1.91%+400Timeline
AVBPARRIVENT BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,027,328 shares; 2025Q1: 3,027,328 shares; 2025Q2: 3,027,328 shares; 2025Q3: 3,027,328 shares; 2025Q4: 3,027,328 shares; 2026Q1: 3,027,328 shares; 2026Q2: 3,027,328 shares; 2026Q3: 3,027,328 shares 3,027,328$91.7M1.68%02026-10-06, 13D/A: 2,875,962 shares, 5.8% of the class, 13D/A filed 2026-10-08 Timeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,943,654 shares; 2025Q1: 6,943,654 shares; 2025Q2: 7,165,006 shares; 2025Q3: 7,165,006 shares; 2025Q4: 7,165,006 shares; 2026Q1: 7,165,006 shares; 2026Q2: 7,165,006 shares; 2026Q3: 7,165,006 shares 7,165,006$82.5M1.51%0Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 413,000 shares; 2025Q1: 547,000 shares; 2025Q2: 593,434 shares; 2025Q3: 429,300 shares; 2025Q4: 365,800 shares; 2026Q1: 262,000 shares; 2026Q2: 262,000 shares; 2026Q3: 199,700 shares 199,700$82.5M1.51%-62,300Timeline
ARQTARCUTIS BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,042,000 shares; 2026Q3: 3,122,100 shares 3,122,100$82.5M1.51%+1,080,100Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 84,400 shares; 2025Q1: 129,000 shares; 2025Q2: 46,500 shares; 2025Q3: 46,500 shares; 2025Q4: 46,500 shares; 2026Q1: 46,500 shares; 2026Q2: 90,700 shares; 2026Q3: 120,400 shares 120,400$81.3M1.49%+29,700Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 130,900 shares; 2025Q1: 201,200 shares; 2025Q2: 336,300 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 161,100 shares; 2026Q3: 219,000 shares 219,000$80.4M1.47%+57,900Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 244,456 shares; 2026Q3: 345,200 shares 345,200$78.6M1.44%+100,744Timeline
ETRAELECTRA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 6,885,170 shares 6,885,170$77.5M1.42%new2026-11-10, Form 4: bought 20,700 shares on 2026-11-10 Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 189,700 shares; 2025Q1: 206,700 shares; 2025Q2: 208,000 shares; 2025Q3: 172,300 shares; 2025Q4: 146,000 shares; 2026Q1: 136,900 shares; 2026Q2: 92,880 shares; 2026Q3: 75,180 shares 75,180$72.1M1.32%-17,700Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,145,302 shares; 2025Q1: 1,532,000 shares; 2025Q2: 1,708,000 shares; 2025Q3: 1,684,000 shares; 2025Q4: 1,842,900 shares; 2026Q1: 1,230,600 shares; 2026Q2: 834,900 shares; 2026Q3: 834,900 shares 834,900$72.1M1.32%0Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 253,000 shares; 2026Q3: 1,200,425 shares 1,200,425$70.7M1.3%+947,425Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 550,000 shares; 2025Q1: 550,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,777,621 shares 2,777,621$69.3M1.27%newTimeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 259,600 shares 259,600$67.9M1.25%newTimeline
CAICARIS LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 3,034,858 shares; 2025Q3: 3,034,858 shares; 2025Q4: 3,116,011 shares; 2026Q1: 2,806,811 shares; 2026Q2: 2,806,811 shares; 2026Q3: 2,192,911 shares 2,192,911$67.2M1.23%-613,900Timeline
ODTXODYSSEY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,001,198 shares; 2026Q3: 3,001,198 shares 3,001,198$66.7M1.22%0Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 371,000 shares; 2026Q1: 322,100 shares; 2026Q2: 1,681,300 shares; 2026Q3: 2,003,700 shares 2,003,700$64.2M1.18%+322,400Timeline
AZNASTRAZENECA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 670,200 shares; 2026Q2: 915,700 shares; 2026Q3: 379,300 shares 379,300$61.8M1.13%-536,400Timeline
CDNACAREDX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 934,800 shares 934,800$60.8M1.11%newTimeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 94,500 shares; 2026Q1: 172,500 shares; 2026Q2: 230,100 shares; 2026Q3: 200,400 shares 200,400$58.4M1.07%-29,700Timeline
ABTABBOTT LABORATORIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 579,000 shares 579,000$57.2M1.05%newTimeline
PRLDPRELUDE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,909,256 shares; 2025Q1: 10,909,256 shares; 2025Q2: 10,909,256 shares; 2025Q3: 10,909,256 shares; 2025Q4: 10,909,256 shares; 2026Q1: 10,909,256 shares; 2026Q2: 13,724,571 shares; 2026Q3: 13,724,571 shares 13,724,571$53.7M0.98%0Timeline
BLSMBLOSSOMHILL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,714,279 shares 2,714,279$50.6M0.93%newTimeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 164,100 shares; 2026Q3: 127,800 shares 127,800$48.8M0.89%-36,300Timeline
STTKSHATTUCK LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,306,127 shares; 2025Q4: 6,306,127 shares; 2026Q1: 6,306,127 shares; 2026Q2: 6,306,127 shares; 2026Q3: 6,306,127 shares 6,306,127$43M0.79%0Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 652,028 shares; 2025Q1: 652,028 shares; 2025Q2: 1,199,300 shares; 2025Q3: 1,139,300 shares; 2025Q4: 1,161,803 shares; 2026Q1: 1,475,403 shares; 2026Q2: 2,209,400 shares; 2026Q3: 1,331,000 shares 1,331,000$41.6M0.76%-878,400Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 478,400 shares; 2025Q3: 689,000 shares; 2025Q4: 875,487 shares; 2026Q1: 875,487 shares; 2026Q2: 676,187 shares; 2026Q3: 988,487 shares 988,487$40.2M0.74%+312,300Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 401,700 shares; 2025Q1: 291,000 shares; 2025Q2: 291,000 shares; 2025Q3: 287,200 shares; 2025Q4: 263,400 shares; 2026Q1: 208,700 shares; 2026Q2: 157,900 shares; 2026Q3: 96,800 shares 96,800$39.4M0.72%-61,100Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 400,000 shares; 2025Q1: 380,000 shares; 2025Q2: 248,512 shares; 2025Q3: 215,152 shares; 2025Q4: 239,800 shares; 2026Q1: 314,100 shares; 2026Q2: 322,900 shares; 2026Q3: 408,000 shares 408,000$38.8M0.71%+85,100Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,611,637 shares; 2025Q1: not reported; 2025Q2: 760,351 shares; 2025Q3: 1,469,494 shares; 2025Q4: 980,400 shares; 2026Q1: 2,052,900 shares; 2026Q2: 2,110,300 shares; 2026Q3: 1,454,572 shares 1,454,572$36.6M0.67%-655,728Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,288,510 shares; 2025Q1: 8,288,510 shares; 2025Q2: 8,288,510 shares; 2025Q3: 8,288,510 shares; 2025Q4: 8,288,510 shares; 2026Q1: 8,288,510 shares; 2026Q2: 8,288,510 shares; 2026Q3: 8,288,510 shares 8,288,510$35.7M0.66%0Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,252,987 shares; 2025Q1: 2,252,987 shares; 2025Q2: 2,252,987 shares; 2025Q3: 2,252,987 shares; 2025Q4: 2,252,987 shares; 2026Q1: 2,252,987 shares; 2026Q2: 4,127,987 shares; 2026Q3: 4,127,987 shares 4,127,987$34.1M0.63%0Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 23,500 shares; 2025Q1: 23,500 shares; 2025Q2: 9,200 shares; 2025Q3: 102,745 shares; 2025Q4: 119,800 shares; 2026Q1: 69,100 shares; 2026Q2: 83,200 shares; 2026Q3: 97,700 shares 97,700$32.5M0.6%+14,500Timeline
PVLAPALVELLA THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 134,600 shares; 2026Q2: 292,360 shares; 2026Q3: 229,860 shares 229,860$31.7M0.58%-62,500Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 386,700 shares; 2025Q2: 427,900 shares; 2025Q3: 531,800 shares; 2025Q4: 253,121 shares; 2026Q1: 213,921 shares; 2026Q2: 117,578 shares; 2026Q3: 170,878 shares 170,878$31.5M0.58%+53,300Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 131,100 shares 131,100$30.4M0.56%newTimeline
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,693,589 shares; 2025Q1: 5,693,589 shares; 2025Q2: 5,693,589 shares; 2025Q3: 5,693,589 shares; 2025Q4: 5,693,589 shares; 2026Q1: 5,693,589 shares; 2026Q2: 5,693,589 shares; 2026Q3: 5,693,589 shares 5,693,589$30M0.55%0Timeline
WSTWEST PHARMACEUTICAL SVSC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 70,600 shares; 2026Q3: 80,180 shares 80,180$29.7M0.55%+9,580Timeline
LTGOLATIGO BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,675,316 shares 1,675,316$28M0.51%newTimeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 84,020 shares; 2025Q4: 85,664 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 314,500 shares 314,500$25M0.46%newTimeline
SCTXSCRIBE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,348,825 shares 1,348,825$24.8M0.46%newTimeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 278,000 shares 278,000$24M0.44%newTimeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 275,000 shares; 2026Q2: 465,346 shares; 2026Q3: 384,520 shares 384,520$23.3M0.43%-80,826Timeline
00Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,048,773 shares; 2025Q1: 12,048,773 shares; 2025Q2: 12,048,773 shares; 2025Q3: 6,210,899 shares; 2025Q4: 6,210,899 shares; 2026Q1: 6,210,899 shares; 2026Q2: 5,680,186 shares; 2026Q3: 5,680,186 shares 5,680,186$22.2M0.41%0
VOGXVOGENX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 968,621 shares 968,621$22.1M0.4%newTimeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 700,000 shares; 2025Q2: 899,281 shares; 2025Q3: 3,641,756 shares; 2025Q4: 3,641,756 shares; 2026Q1: 2,693,929 shares; 2026Q2: 2,015,000 shares; 2026Q3: 1,555,900 shares 1,555,900$21M0.38%-459,100Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,333,333 shares; 2026Q3: 3,333,333 shares 3,333,333$20.9M0.38%0Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 635,000 shares; 2026Q2: 3,959,900 shares; 2026Q3: 3,959,900 shares 3,959,900$20.4M0.37%0Timeline
APMDAPNIMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 925,000 shares 925,000$20.3M0.37%newTimeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 458,500 shares; 2025Q4: 737,400 shares; 2026Q1: 2,136,149 shares; 2026Q2: 1,807,486 shares; 2026Q3: 811,000 shares 811,000$19.6M0.36%-996,486Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,087,462 shares; 2025Q1: 3,087,462 shares; 2025Q2: 719,901 shares; 2025Q3: 466,601 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,230,939 shares 2,230,939$19.6M0.36%newTimeline
PYXSPYXIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 8,361,917 shares 8,361,917$19.5M0.36%newTimeline
ACHVACHIEVE LIFE SCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,344,200 shares 2,344,200$19M0.35%newTimeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 380,000 shares; 2025Q4: 367,900 shares; 2026Q1: 465,700 shares; 2026Q2: 546,522 shares; 2026Q3: 185,022 shares 185,022$18.3M0.34%-361,500Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 509,100 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 61,600 shares; 2026Q2: 61,600 shares; 2026Q3: 79,400 shares 79,400$17.9M0.33%+17,800Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 187,199 shares; 2026Q1: 180,599 shares; 2026Q2: 420,600 shares; 2026Q3: 238,900 shares 238,900$17.8M0.33%-181,700Timeline
WATWATERS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 40,300 shares; 2026Q3: 40,300 shares 40,300$17.7M0.32%0Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 804,000 shares; 2026Q2: 365,400 shares; 2026Q3: 443,900 shares 443,900$16.9M0.31%+78,500Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 505,000 shares 505,000$16.4M0.3%newTimeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 22,362,850 shares; 2025Q1: 22,362,850 shares; 2025Q2: 15,219,994 shares; 2025Q3: 15,219,994 shares; 2025Q4: 15,219,994 shares; 2026Q1: 15,219,994 shares; 2026Q2: 15,219,994 shares; 2026Q3: 15,219,994 shares 15,219,994$15.8M0.29%0Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 182,600 shares 182,600$15.6M0.29%newTimeline
NPCENEUROPACE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,406,335 shares; 2025Q1: 3,406,335 shares; 2025Q2: 2,614,184 shares; 2025Q3: 2,614,184 shares; 2025Q4: 2,406,335 shares; 2026Q1: 2,096,527 shares; 2026Q2: 1,505,125 shares; 2026Q3: 1,055,125 shares 1,055,125$14.5M0.27%-450,000Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 4,166,000 shares; 2025Q2: 4,166,000 shares; 2025Q3: 4,166,000 shares; 2025Q4: 4,166,000 shares; 2026Q1: 4,166,000 shares; 2026Q2: 3,934,296 shares; 2026Q3: 3,853,472 shares 3,853,472$14.5M0.27%-80,824Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,900 shares; 2026Q1: 52,000 shares; 2026Q2: 70,500 shares; 2026Q3: 70,500 shares 70,500$14.5M0.27%0Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,120,000 shares; 2025Q2: 3,308,400 shares; 2025Q3: 3,308,400 shares; 2025Q4: 3,190,700 shares; 2026Q1: 2,454,400 shares; 2026Q2: 1,430,293 shares; 2026Q3: 965,300 shares 965,300$13.8M0.25%-464,993Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 151,000 shares; 2025Q1: 159,900 shares; 2025Q2: 210,287 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 26,200 shares 26,200$13.7M0.25%newTimeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 3,704,959 shares; 2025Q2: 3,704,959 shares; 2025Q3: 3,704,959 shares; 2025Q4: 3,561,655 shares; 2026Q1: 3,530,702 shares; 2026Q2: 2,555,877 shares; 2026Q3: 2,469,959 shares 2,469,959$13M0.24%-85,918Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 194,300 shares 194,300$12.7M0.23%newTimeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 901,500 shares; 2025Q4: 1,741,800 shares; 2026Q1: 1,425,200 shares; 2026Q2: 1,852,000 shares; 2026Q3: 1,506,000 shares 1,506,000$12.5M0.23%-346,000Timeline
STROSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 801,144 shares; 2026Q2: 743,944 shares; 2026Q3: 743,944 shares 743,944$12M0.22%0Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 495,900 shares; 2026Q3: 806,000 shares 806,000$11.8M0.22%+310,100Timeline
SPRBSPRUCE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 200,000 shares; 2026Q3: 242,800 shares 242,800$11.8M0.22%+42,800Timeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,172,287 shares; 2025Q1: 1,172,287 shares; 2025Q2: 1,172,287 shares; 2025Q3: 1,172,287 shares; 2025Q4: 1,597,287 shares; 2026Q1: 1,737,287 shares; 2026Q2: 1,737,287 shares; 2026Q3: 1,665,656 shares 1,665,656$11.4M0.21%-71,631Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,125,000 shares; 2026Q1: 3,602,450 shares; 2026Q2: 3,947,850 shares; 2026Q3: 3,203,050 shares 3,203,050$10.8M0.2%-744,800Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,000,000 shares; 2026Q3: 2,000,000 shares 2,000,000$9.74M0.18%0Timeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 758,566 shares; 2025Q1: 758,566 shares; 2025Q2: 1,210,300 shares; 2025Q3: 1,766,100 shares; 2025Q4: 1,954,426 shares; 2026Q1: 983,600 shares; 2026Q2: 524,700 shares; 2026Q3: 524,700 shares 524,700$9.07M0.17%0Timeline
KROSKEROS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,018,734 shares; 2025Q1: 1,018,734 shares; 2025Q2: 1,018,734 shares; 2025Q3: 1,018,734 shares; 2025Q4: 804,212 shares; 2026Q1: 759,155 shares; 2026Q2: 759,155 shares; 2026Q3: 759,155 shares 759,155$8.65M0.16%0Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,610,600 shares; 2026Q1: 4,715,864 shares; 2026Q2: 3,631,195 shares; 2026Q3: 1,670,079 shares 1,670,079$6.3M0.12%-1,961,116Timeline
ACETADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,027,944 shares; 2026Q1: 1,027,944 shares; 2026Q2: 844,787 shares; 2026Q3: 844,787 shares 844,787$6.03M0.11%0Timeline
YARWYARROW BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 266,306 shares 266,306$6M0.11%newTimeline
XLOXILIO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 592,300 shares; 2026Q3: 592,300 shares 592,300$5.36M0.1%0Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 921,959 shares; 2025Q1: 921,959 shares; 2025Q2: 921,959 shares; 2025Q3: 790,901 shares; 2025Q4: 790,901 shares; 2026Q1: 711,811 shares; 2026Q2: 752,153 shares; 2026Q3: 711,811 shares 711,811$5.05M0.09%-40,342Timeline
IMUXIMMUNIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 475,804 shares 475,804$4.42M0.08%newTimeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 186,145 shares; 2026Q3: 47,326 shares 47,326$4.21M0.08%-138,819Timeline
IMAIMAGENEBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 378,556 shares; 2025Q4: 378,556 shares; 2026Q1: 378,556 shares; 2026Q2: 909,269 shares; 2026Q3: 909,269 shares 909,269$4.16M0.08%0Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 263,100 shares; 2025Q4: 299,800 shares; 2026Q1: 265,800 shares; 2026Q2: not reported; 2026Q3: 18,600 shares 18,600$4.12M0.08%newTimeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,926,423 shares; 2025Q3: 1,926,423 shares; 2025Q4: 1,102,730 shares; 2026Q1: 548,163 shares; 2026Q2: 548,163 shares; 2026Q3: 548,163 shares 548,163$4.05M0.07%0Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 40,000 shares; 2026Q2: 93,000 shares; 2026Q3: 81,000 shares 81,000$4.04M0.07%-12,000Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 8,000 shares 8,000$4.03M0.07%newTimeline
AORTARTIVION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 151,000 shares; 2026Q2: 175,000 shares; 2026Q3: 175,000 shares 175,000$3.99M0.07%0Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 574,600 shares; 2026Q1: 226,600 shares; 2026Q2: 226,600 shares; 2026Q3: 166,102 shares 166,102$3.87M0.07%-60,498Timeline
ALXOALX ONCOLOGY HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,866,256 shares; 2026Q2: 2,866,256 shares; 2026Q3: 2,742,968 shares 2,742,968$3.81M0.07%-123,288Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 115,000 shares; 2026Q3: 42,300 shares 42,300$3.72M0.07%-72,700Timeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,390,576 shares; 2026Q3: 1,315,355 shares 1,315,355$3.64M0.07%-75,221Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 54,300 shares 54,300$3.26M0.06%newTimeline
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 23,200 shares; 2026Q1: 49,100 shares; 2026Q2: 49,100 shares; 2026Q3: 49,100 shares 49,100$3.18M0.06%0Timeline
BRKRBRUKER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 555,789 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 48,400 shares 48,400$3.13M0.06%newTimeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 653,743 shares; 2025Q2: 197,900 shares; 2025Q3: 197,900 shares; 2025Q4: 154,400 shares; 2026Q1: not reported; 2026Q2: 35,581 shares; 2026Q3: 34,600 shares 34,600$2.72M0.05%-981Timeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,796,000 shares; 2025Q4: 2,468,314 shares; 2026Q1: 1,069,147 shares; 2026Q2: 1,069,147 shares; 2026Q3: 739,691 shares 739,691$2.42M0.04%-329,456Timeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 13,300 shares; 2026Q3: 13,300 shares 13,300$2.26M0.04%0Timeline
NSPRINSPIREMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,133,405 shares; 2025Q1: 2,133,405 shares; 2025Q2: 2,133,405 shares; 2025Q3: 2,133,405 shares; 2025Q4: 3,133,405 shares; 2026Q1: 3,133,405 shares; 2026Q2: 3,133,405 shares; 2026Q3: 3,133,405 shares 3,133,405$2.09M0.04%0Timeline
UNCYUNICYCIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 387,000 shares 387,000$1.82M0.03%newTimeline
EPRXEUPRAXIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 269,000 shares; 2026Q3: 194,720 shares 194,720$1.77M0.03%-74,280Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 157,300 shares; 2026Q1: not reported; 2026Q2: 220,000 shares; 2026Q3: 220,000 shares 220,000$1.69M0.03%0Timeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 161,000 shares; 2026Q3: 161,000 shares 161,000$1.33M0.02%0Timeline
TRAWTRAWS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 605,531 shares; 2025Q1: 605,531 shares; 2025Q2: 605,531 shares; 2025Q3: 605,531 shares; 2025Q4: 605,531 shares; 2026Q1: 605,531 shares; 2026Q2: 1,203,260 shares; 2026Q3: 1,203,260 shares 1,203,260$714K0.01%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
PTGXPROTAGONIST THERAPEUTICS INC COMcall150,000$21.1M0
ABVXABIVAX SA SPONSORED ADScall100,000$9.9M-100,000
RVMDREVOLUTION MEDICINES INC Stockcall30,000$6.16M-20,000
TNGXTANGO THERAPEUTICS INC COMcall150,000$3.74Mnew
BCRXBIOCRYST PHARMACEUTICALS INC Stockcall250,000$2.08Mnew
DNAGINKGO BIOWORKS HOLDINGS INC COMMON STOCKcall100,000$1.28Mnew
SLSSELLAS LIFE SCIENCES GROUP I COM NEWput100,000$1.23M+7,500
MDXHMDXHEALTH SA SHS NEWcall1,243,060$120Knew

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
TRAVERE THERAPEUTICS INCTRAVERE THERAPEUTICS INC NOTE 0.500% 5/1principal5,000,000$5.94M0
REVOLUTION MEDICINES INCREVOLUTION MEDICINES INC NOTE 0.500% 5/0principal3,500,000$4.52M0

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
DYNDYNE THERAPEUTICS INC3,235,684$71.9Mshares
CGONCG ONCOLOGY INC972,800$69.1Mshares
BSXBOSTON SCIENTIFIC CORP1,483,200$63.3Mshares
XENEXENON PHARMACEUTICALS INC892,471$53.9Mshares
BMYBRISTOL-MYERS SQUIBB CO925,000$53.3Mshares
SYKSTRYKER CORPORATION159,100$50.1Mshares
XBISPDR SERIES TRUST300,000$47.5Mput
ELVELEVANCE HEALTH INC FORMERLY114,700$44.4Mshares
CRNXCRINETICS PHARMACEUTICALS IN999,000$37.4Mshares
SNDXSYNDAX PHARMACEUTICALS INC1,542,000$33.7Mshares
FBRXFORTE BIOSCIENCES INC1,577,705$33.5Mshares
IRONDISC MEDICINE INC357,535$26.2Mshares
HELPCYBIN INC3,271,400$21.6Mshares
VERAVERA THERAPEUTICS INC369,596$15.9Mshares
MNPRMONOPAR THERAPEUTICS INC157,423$14.6Mshares
LFSTLIFESTANCE HEALTH GROUP INC947,400$10.1Mshares
TARAPROTARA THERAPEUTICS INC2,220,000$8.48Mshares
PHVSPHARVARIS N V205,400$7.1Mshares
ANROALTO NEUROSCIENCE INC257,852$6.8Mshares
PVLAPALVELLA THERAPEUTICS INC NE40,000$6.11Mcall
BCAXBICARA THERAPEUTICS INC191,100$5.67Mshares
PTGXPROTAGONIST THERAPEUTICS INC42,100$5.16Mshares
ALNYALNYLAM PHARMACEUTICALS INC17,000$5.12Mshares
PALIPALISADE BIO INC2,333,000$4.88Mshares
ATAIATAIBECKLEY INC797,500$4.2Mshares
UNHUNITEDHEALTH GROUP INC10,000$4.16Mcall
ELVELEVANCE HEALTH INC FORMERLY10,000$3.87Mcall
NMRANEUMORA THERAPEUTICS INC.2,139,882$3.64Mshares
ACADACADIA PHARMACEUTICALS INC137,000$3.47Mshares
AMLXAMYLYX PHARMACEUTICALS INC183,400$3.29Mshares
TYRATYRA BIOSCIENCES INC102,000$3.26Mshares
RAPPRAPPORT THERAPEUTICS INC76,616$3.19Mshares
AGMBAGOMAB THERAPEUTICS NV192,740$2.5Mshares
ACRSACLARIS THERAPEUTICS INC421,500$2.23Mshares
CYTKCYTOKINETICS INC25,800$2.2Mshares
OVIDOVID THERAPEUTICS INC747,000$2.01Mshares
COGENT BIOSCIENCES INCCOGENT BIOSCIENCES INC1,000,000$1.23Mprincipal
VIRIDIAN THERAPEUTICS INCVIRIDIAN THERAPEUTICS INC1,000,000$1.07Mprincipal

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001172661-26-005349 base2026-11-16

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
Form 4 0000947871-26-001038 WINDWARD BIO GROUP AG2026-11-18
13G/A 0000947871-26-001037 LXEO2026-11-16
13G 0000947871-26-001036 VOGX2026-11-16
13G 0000947871-26-001035 PYXS2026-11-16
13G/A 0000947871-26-001034 HELP2026-11-16
13G/A 0000947871-26-001033 SPRB2026-11-16
13G/A 0000947871-26-001032 IMUX2026-11-16
13G/A 0000947871-26-001031 FBRX2026-11-16
13F-HR 0001172661-26-005349 Quarter ended 2026-09-302026-11-16
Form 3 0000947871-26-001015 WINDWARD BIO GROUP AG2026-11-12
Form 4 0000947871-26-001010 Electra Therapeutics, Inc.2026-11-10
13D 0000947871-26-000996 ASPE2026-11-06
Form 4 0000947871-26-000985 Electra Therapeutics, Inc.2026-11-05
Form 4 0000947871-26-000980 Aspen Neuroscience, Inc.2026-11-04
Form 3 0000947871-26-000964 Aspen Neuroscience, Inc.2026-10-29
13D/A 0000947871-26-000931 AVBP2026-10-08
13D 0000947871-26-000917 ADRX2026-10-02
Form 4 0000947871-26-000910 ADARx Pharmaceuticals, Inc.2026-09-30
13D 0000947871-26-000898 ETRA2026-09-25
13F-HR 0001172661-26-003740 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001172661-26-002369 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001172661-26-001119 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001172661-25-005047 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001172661-25-003514 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001172661-25-002355 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001172661-25-001136 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001172661-24-005167 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001172661-24-003539 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001172661-24-002506 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001172661-24-001461 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001172661-23-004019 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001172661-23-003177 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001172661-23-002323 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001172661-23-001310 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001172661-22-002553 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001172661-22-001998 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001172661-22-001456 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001172661-22-000795 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001172661-21-002332 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001172661-21-001841 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001172661-21-001345 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0001172661-21-000786 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR 0001172661-20-002295 Quarter ended 2020-09-302020-11-16acceptance time not in the bulk data set
13F-HR 0001172661-20-001859 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-HR 0001172661-20-001407 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-HR 0001172661-20-000859 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-HR 0001172661-19-002352 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001172661-19-001883 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR 0001172661-19-001382 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR 0001172661-19-000868 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR 0001172661-18-002168 Quarter ended 2018-09-302018-11-14acceptance time not in the bulk data set
13F-HR 0001172661-18-001660 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR 0001172661-18-001239 Quarter ended 2018-03-312018-05-15acceptance time not in the bulk data set
13F-HR 0001172661-18-000795 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set
13F-HR 0001172661-17-002146 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-HR 0001172661-17-001699 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-HR 0001172661-17-001216 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-HR 0001172661-17-000766 Quarter ended 2016-12-312017-02-14acceptance time not in the bulk data set
13F-HR 0001172661-16-004318 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0001172661-16-003893 Quarter ended 2016-06-302016-08-15acceptance time not in the bulk data set
13F-HR 0001172661-16-003439 Quarter ended 2016-03-312016-05-16acceptance time not in the bulk data set
13F-HR 0001172661-16-002937 Quarter ended 2015-12-312016-02-16acceptance time not in the bulk data set
13F-HR/A 0001172661-15-002104 Quarter ended 2015-09-302015-11-18acceptance time not in the bulk data set
13F-HR 0001172661-15-001946 Quarter ended 2015-09-302015-11-13acceptance time not in the bulk data set
13F-HR/A 0001172661-15-001668 Quarter ended 2015-06-302015-08-20acceptance time not in the bulk data set
13F-HR 0001172661-15-001654 Quarter ended 2015-06-302015-08-14acceptance time not in the bulk data set
13F-HR 0001172661-15-001221 Quarter ended 2015-03-312015-05-15acceptance time not in the bulk data set
13F-HR 0001172661-15-000419 Quarter ended 2014-12-312015-02-13acceptance time not in the bulk data set
13F-HR 0001172661-14-001849 Quarter ended 2014-09-302014-11-14acceptance time not in the bulk data set
13F-HR 0001172661-14-001491 Quarter ended 2014-06-302014-08-14acceptance time not in the bulk data set
13F-HR 0001172661-14-001118 Quarter ended 2014-03-312014-05-15acceptance time not in the bulk data set
13F-HR 0001172661-14-000746 Quarter ended 2013-12-312014-02-14acceptance time not in the bulk data set
13F-HR 0001172661-13-001529 Quarter ended 2013-09-302013-11-14acceptance time not in the bulk data set
13F-HR 0001172661-13-001218 Quarter ended 2013-06-302013-08-14acceptance time not in the bulk data set